By Emily Field ( September 17, 2015, 10:18 PM EDT) -- A spinal patient has asked the U.S. Supreme Court to review a Tenth Circuit ruling that her injury claims over Medtronic Inc.'s Infuse bone graft device are pre-empted despite them involving off-label uses not approved by the U.S. Food and Drug Administration, saying the decision created a circuit split....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.